$178 Million is the total value of Omega Fund Management, LLC's 12 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NUVB | Nuvation Bio | $27,130,212 | +8.4% | 15,072,340 | 0.0% | 15.20% | -6.9% | |
| ALPN | Alpine Immune Sciences | $20,864,082 | +33.2% | 2,029,580 | 0.0% | 11.69% | +14.4% | |
| IKNA | Ikena Oncology | $14,754,247 | +90.1% | 2,249,123 | 0.0% | 8.27% | +63.3% | |
| Theseus Pharmaceuticals | $6,638,099 | +5.1% | 711,479 | 0.0% | 3.72% | -9.8% | ||
| KRON | Kronos Bio | $6,567,447 | +17.8% | 3,818,283 | 0.0% | 3.68% | +1.2% | |
| SANA | Sana Biotechnology, Inc. | $5,028,750 | +82.3% | 843,750 | 0.0% | 2.82% | +56.5% | |
| SPRB | Spruce Biosciences | $4,646,197 | -2.7% | 2,161,022 | 0.0% | 2.60% | -16.4% | |
| IMUX | Immunic Inc | $4,488,282 | +68.5% | 1,788,160 | 0.0% | 2.52% | +44.7% | |
| Syros Pharmaceuticals | $791,500 | +18.0% | 251,270 | 0.0% | 0.44% | +1.1% | ||
| Senti Biosciences, Inc. | $122,762 | -46.9% | 195,792 | 0.0% | 0.07% | -54.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Paratek Pharmaceuticals, Inc. | 34 | Q1 2023 | 39.1% |
| FibroGen, Inc. | 28 | Q3 2021 | 14.3% |
| Jounce Therapeutics | 25 | Q1 2023 | 11.6% |
| Replimune Group | 24 | Q2 2024 | 47.2% |
| Pieris Pharmaceuticals | 23 | Q1 2021 | 5.2% |
| Morphic Holding | 21 | Q2 2024 | 22.0% |
| Immunic Inc | 21 | Q2 2024 | 9.0% |
| Cidara Therapeutics | 20 | Q3 2021 | 5.8% |
| Dicerna Pharmaceuticals | 18 | Q1 2019 | 3.7% |
| Egalet | 17 | Q4 2018 | 19.6% |
View Omega Fund Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-28 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View Omega Fund Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.